title: The economic burden of diabetes.
abstract: New research provides revised comprehensive estimates that suggest that the U.S. national economic burden of pre-diabetes and diabetes reached $218 billion in 2007. This estimate includes $153 billion in higher medical costs and $65 billion in reduced productivity. The average annual cost per case is $2,864 for undiagnosed diabetes, $9,975 for diagnosed diabetes ($9,677 for type 2 and $14,856 for type 1), and $443 for pre-diabetes (medical costs only). For each American, regardless of diabetes status, this burden represents a cost of approximately $700 annually. These results underscore the urgency of better understanding how prevention and treatment strategies may or may not help reduce costs.
authors.affiliation: Lewin Group, Falls Church, Virginia, USA. tim.dall@lewin.com
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Dall
authors.forename: Yiduo
authors.initials: Y
authors.lastname: Zhang
authors.forename: Yaozhu J
authors.initials: YJ
authors.lastname: Chen
authors.forename: William W
authors.initials: WW
authors.lastname: Quick
authors.forename: Wenya G
authors.initials: WG
authors.lastname: Yang
authors.forename: Jeanene
authors.initials: J
authors.lastname: Fogli
mesh_terms: D017281:Cost of Illness; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000191:economics* / Q000453:epidemiology; D017048:Health Care Costs / Q000706:statistics & numerical data*; D005102:Health Expenditures / Q000706:statistics & numerical data*; D006801:Humans; D015995:Prevalence; D014481:United States / Q000453:epidemiology